Posted on 3 月 17, 20213/17/21
Change Is Happening in the EU: What Pharma Companies Need to Know About the European Union’s New Pharmaceutical Strategy
Posted on 10 月 13, 202010/13/20
eBook – 2020 Stories That Shaped Commercialization
Posted on 7 月 16, 20207/16/20
CMS Proposed Medicaid Rule: Best Price Impacts of Value-Based Purchasing, Co-Pay Assistance Programs, and More
Posted on 7 月 2, 20207/2/20
ICER’s Alternative Pricing Models: New Threats to Biopharmaceutical’s Profitability and Innovation
Posted on 6 月 28, 20206/28/20
COVID-19’s Impact on Brand Access
Posted on 6 月 24, 20206/24/20
Brand Access Marketplace Dynamics: Respiratory
Posted on 6 月 24, 20206/24/20
Brand Access Marketplace Dynamics: Multiple Sclerosis
Posted on 6 月 24, 20206/24/20
Brand Access Marketplace Dynamics: HIV
Posted on 6 月 24, 20206/24/20
Brand Access Marketplace Dynamics: Autoimmune
Posted on 4 月 29, 20204/29/20